Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-06

FDA Approved: MIRTAZAPINE — Supplemental Application (SQUARE PHARMACEUTICALS LIMITED)

View source ↗

Summary

FDA approved a supplemental application for mirtazapine from Square Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)